Skip to main content
SpringerLink
Log in

Percutaneous Options, Patient Selection, and Preoperative Evaluation

  • Chapter
  • First Online:
Percutaneous Interventions for Structural Heart Disease

  • 837 Accesses

Abstract

Although debated, patent foramen ovale (PFO) is still a popular field of interest for catheter-based interventions. While there is a common agreement about the management of patients with interatrial left-to-right shunts as secundum atrial septal defects, there is no complete agreement on which is the best management of PFO patients. In PFO patients, the real challenge for the clinician, besides secondary prevention of recurrent stroke, is to understand which are the higher-risk patients to refer for treatment and which is the proper device to use among the variety of double-umbrella or stent devices in the market. Different meta-analysis and registries suggested that interventional therapy is the most effective treatment at least with a specific device, but so far only few robust evidences have been only recently produced. The main anatomical-functional characteristics of interatrial septum, obtained with the current available diagnostic tools, such as transcranial Doppler, transthoracic, and transesophageal echocardiography together with a meticulous evaluation of patient’s history and clinical features, remain of paramount importance in patient selection and preoperative evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marelli AJ, Mackie AS, Msc RI, Rahme E, Pilote L. Congenital heart disease in the general population. Changing prevalence and age distribution. Circulation. 2007;115:163–72.

    Article  PubMed  Google Scholar 

  2. Kilner PJ, Yang GZ, Wilkes AJ, Mohiaddin RH, Firmin DN, Yacoub MH. Asymmetric redirection of flow through the heart. Nature. 2000;404:759–61.

    Article  CAS  PubMed  Google Scholar 

  3. Rigatelli G. Patent foramen ovale: the evident paradox between the apparently simple treatment and the really complex pathophysiology. J Cardiovasc Med (Hagerstown). 2007;8:300–4.

    Article  Google Scholar 

  4. Langholz D, Louie EK, Konstadt SN, Rao TL, Scanlon PJ. Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol. 1991;18:1112–7.

    Article  CAS  PubMed  Google Scholar 

  5. Nootens MT, Berarducci LA, Kaufmann E, Devries S, Rich S. The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest. 1993;104:1673–5.

    Article  CAS  PubMed  Google Scholar 

  6. Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with mayor pulmonary embolism. Circulation. 1998;97:1946–51.

    Article  CAS  PubMed  Google Scholar 

  7. Shanoudy H, Soliman A, Raggi P, Liu JW, Russell DC, Jarmukli NF. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest. 1998;113:91–6.

    Article  CAS  PubMed  Google Scholar 

  8. Soliman A, Shanoudy H, Liu J, Russell DC, Jarmukli NF. Increased prevalence of patent foramen ovale in patient with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr. 1999;12:99–105.

    Article  CAS  PubMed  Google Scholar 

  9. Rietvel AP, Merrman L, Essed CD, Trimbos JB, Hagemiejer F. Right-to-left shunt, with severe hypoxemia, at the atrial level in a patient with hemodynamically important right ventricular infarction. JACC. 1982;2:776–9.

    Article  Google Scholar 

  10. Giebler R, Kollenberg B, Pohlen G, Peters J. Effect of positive end-expiratory pressure on the incidence of venous air embolism and on the cardiovascular response to the sitting position during neurosurgery. Br J Anaesth. 1998;80:30–5.

    Article  CAS  PubMed  Google Scholar 

  11. Gallaher ME, Sperling DR, Gwinn JL, Meyer BW, Fyler DC. Functional drainage of the inferior vena cava into the left atrium-three cases. Am J Cardiol. 1963;12:561–6.

    Article  CAS  PubMed  Google Scholar 

  12. Schoevvaerdts D, Gonzalez M, Evrard P, Buche M, Installe E. Patent foramen ovale: a cause of significant post-coronary and bypass grafting morbidity. Cardiovasc Surg. 2002;10:615–7.

    Article  Google Scholar 

  13. Laybourn KA, Martin ET, Cooper RAS, Holman WL. Platypnea and orthodeoxia: shunting associated with an aortic aneurysm. J Thorac Cardiovasc Surg. 1977;113:955–6.

    Article  Google Scholar 

  14. Smeenk FWJM, Postmus PE. Interatrial right-to-left shunting developing after pulmonary resection in the absence of elevated right-sided pressure. Chest. 1993;103:528–31.

    Article  CAS  PubMed  Google Scholar 

  15. Klepper JI, Seifer F, Lawson WF, et al. Intracardiac right-to-left shunting following cardiac surgery. Am Heart J. 1988;116:189–92.

    Article  CAS  PubMed  Google Scholar 

  16. Sievert H, Ruygrok P, Salkeld M, Baumgartner H, Meier B, Windecker S, Juliard JM, Aubry P, Tiefenbacher C, Krumsdorf U, Vermeersch P, Ewert P, Piéchaud JF. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv. 2009;73(3):368–73. doi:10.1002/ccd.21809.

    PubMed  Google Scholar 

  17. Aral M, Mullen M. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2015;85(6):1058–65.

    Article  PubMed  Google Scholar 

  18. Sievert H, Wunderlich N, Reiffenstein I, Ruygrok P, Grube E, Buellesfeld L, Meier B, Schofer J, Muller D, Jones RK, Gillam L. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study. Catheter Cardiovasc Interv. 2014;83(7):1135–43. doi:10.1002/ccd.24565. Epub 2013 Nov 27.

    Article  PubMed  Google Scholar 

  19. Mügge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785–92.

    Article  PubMed  Google Scholar 

  20. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxical Embolism Study Group. Neurology. 1996;46(5):1301–5.

    Article  CAS  PubMed  Google Scholar 

  21. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. 1999;15(1):57–64.

    CAS  PubMed  Google Scholar 

  22. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740–6.

    Article  CAS  PubMed  Google Scholar 

  23. Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001;22(3):261–8.

    Article  CAS  PubMed  Google Scholar 

  24. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial Septal Aneurysm. Stroke. 2002;33(3):706–11.

    Article  CAS  PubMed  Google Scholar 

  25. Furlan AJ, CLOSURE I Investigators. PFO closure: CLOSURE. Stroke. 2013;44(6 Suppl 1):S45–7.

    Article  PubMed  Google Scholar 

  26. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–9.

    Article  CAS  PubMed  Google Scholar 

  27. Serena J, Marti-Fàbregas J, Santamarina E, Rodríguez JJ, Perez-Ayuso MJ, Masjuan J, Segura T, Gállego J, Dávalos A, CODICIA, Right-to-Left Shunt in Cryptogenic Stroke Study, Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke. 2008;39(12):3131–6.

    Article  PubMed  Google Scholar 

  28. Horner S, Niederkorn K, Gattringer T, Furtner M, Topakian R, Lang W, Maier R, Gamillscheg A, Fazekas F. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol. 2013;260(1):260–7.

    Article  PubMed  Google Scholar 

  29. Khattab AA, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design. Trials. 2011;12:56.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Carroll JD, Saver JL, Thaler DE, for the RESPECT Investigators, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092–100.

    Article  CAS  PubMed  Google Scholar 

  31. Ma B, Liu G, Chen X, Zhang J, Liu Y, Shi J. Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies. J Stroke Cerebrovasc Dis. 2014;23(5):1207–15.

    Article  PubMed  Google Scholar 

  32. Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C. Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. EuroIntervention. 2014;9(11):1342–9.

    Article  PubMed  Google Scholar 

  33. Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6(12):1316–23.

    Article  PubMed  Google Scholar 

  34. Pickett CA, Villines TC, Ferguson MA, Hulten EA. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014;41(4):357–67.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015;36(2):120–8.

    Article  PubMed  Google Scholar 

  36. Patti G, Pelliccia F, Gaudio C, Greco C. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol. 2015;115(6):837–43.

    Article  PubMed  Google Scholar 

  37. Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache. 2006;46:429–34.

    Article  PubMed  Google Scholar 

  38. Kaaro J, Partonene T, Naik P, Hadjikhani N. Is migraine a lateralization defect? Neuroreport. 2008;19:1351–3.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Rigatelli G, Aggio S, Cardaioli P, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? JACC Cardiovasc Interv. 2009;2:655–62.

    Article  PubMed  Google Scholar 

  40. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67:221–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Tarantini G, D'Amico G, Bettella N, Mojoli M, Rigatelli G. Patent foramen ovale closure and migraine time course: clues for positive interaction. Int J Cardiol. 2015;195:235–6.

    Article  PubMed  Google Scholar 

  42. Baker JE, Stratmann G, Hoopes C, Donateillo R, Tseng E, Russell IA. Profound hypoxemia resulting from shunting across an inadvertent atrial septal tear after left ventricular assist device placement. Anesth Analg. 2004;98:937–40.

    Article  PubMed  Google Scholar 

  43. Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K. Patent foramen ovale complicating heart transplantation. A window on posttransplantation hemodynamics. Chest. 1987;92:569–72.

    Article  CAS  PubMed  Google Scholar 

  44. Rigatelli G, Faggian G, Cardaioli P, Mazzucco A. Contemporary management of patent foramen ovale in patients undergoing ventricular assisting devices or heart transplantation. J Cardiovasc Med (Hagerstown). 2009;10(1):9–12.

    Article  Google Scholar 

  45. Thaler DE, Di Angelantonio E, Di Tullio MR, et al. The risk of paradoxical embolism (RoPE) study: initial description of the complete database. Int J Stroke. 2013;8:612–9.

    Article  PubMed  Google Scholar 

  46. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; American Society of Echocardiography’s Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.

    Google Scholar 

  47. Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765–7.

    Article  PubMed  Google Scholar 

  48. Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really “shut the door?”A prospective study with transcranial doppler. Stroke. 2004;35:2140–4.

    Article  CAS  PubMed  Google Scholar 

  49. Rigatelli G, Dell'Avvocata F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Mandapaka S, Kuruvilla J, Chen JP, Nanjundappa A. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J Am Coll Cardiol. 2011;58(21):2257–61.

    Article  PubMed  Google Scholar 

  50. Pristipino C, Anzola GP, Ballerini L, Bartorelli A, Cecconi M, Chessa M, Donti A, Gaspardone A, Neri G, Onorato E, Palareti G, Rakar S, Rigatelli G, Santoro G, Toni D, Ussia GP, Violini R, Italian Society of Invasive Cardiology (SICI-GISE), Italian Stroke Association (ISA-AIS), Italian Association of Hospital Neurologists, Neuroradiologists, Neurosurgeons (SNO), Congenital Heart Disease Study Group of Italian Society Of Cardiology, Italian Association Of Hospital Cardiologists (ANMCO), Italian Society Of Pediatric Cardiology (SICP), Italian Society of Cardiovascular Echography (SIEC), Italian Society of Hemostasis and Thrombosis (SISET). Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. Catheter Cardiovasc Interv. 2013;82(1):122–9.

    Article  PubMed  Google Scholar 

  51. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, et al.; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042–50.

    Google Scholar 

  52. Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006;175:911–7.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–31.

    Article  PubMed  Google Scholar 

  54. Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysm in patients with cerebral ischemic events. Circulation. 1999;99:1942–4.

    Article  CAS  PubMed  Google Scholar 

  55. Santamarina E, Gonzalez-Alujas MT, Munoz V, Rovira A, Rubiera M, Ribo M, et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging. 2006;16:334–40.17.

    Article  PubMed  Google Scholar 

  56. Olivares-Reyes A, Chan S, Lazar EJ, Bandlamudi K, Narla V, Ong K. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr. 1997;10:644–56.

    Article  CAS  PubMed  Google Scholar 

  57. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17:231–3.

    Article  PubMed  Google Scholar 

  58. Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari’s network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol. 1995;26:203–10.

    Article  CAS  PubMed  Google Scholar 

  59. Rigatelli G, Dell'Avvocata F, Braggion G, Giordan M, Chinaglia M, Cardatoli P. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovasc Interv. 2008;72:973–6.

    Article  PubMed  Google Scholar 

  60. Agmon Y, Meissner I, Tajik AJ, Seward JB, Petterson TM, Christianson TJ, O'Fallon WM, Wiebers DO, Khandheria BK. Clinical, laboratory, and transesophageal echocardiographic correlates of interatrial septal thickness: a population-based transesophageal echocardiographic study. J Am Soc Echocardiogr. 2005;18:175–82.

    Article  PubMed  Google Scholar 

  61. Christoph MH, Thomas K, Stefan PL, Torsten TB, Volkmar N. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest. 2003;124:2068–73.

    Article  Google Scholar 

  62. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, Rodriguez LL, Kapadia SR. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol. 2009;103:124–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Congenital Heart Disease Interventions, Cardiovascular Diagnosis and Endoluminal, Interventions Unit, Rovigo General Hospital, viale Tre Martiri, 45100, Rovigo, Italy

    Gianluca Rigatelli

Authors
  1. Gianluca Rigatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gianluca Rigatelli .

Editor information

Editors and Affiliations

  1. Department of Cardiology, Mirano Hospital, Mirano, Italy

    Bernhard Reimers

  2. Cardiac and Endovascular Interventions, First Coast Cardiovascular Institute, Jacksonville, Florida, USA

    Issam Moussa

  3. Department of Cardiology, Mirano Hospital, Mirano, Italy

    Andrea Pacchioni

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rigatelli, G. (2017). Percutaneous Options, Patient Selection, and Preoperative Evaluation. In: Reimers, B., Moussa, I., Pacchioni, A. (eds) Percutaneous Interventions for Structural Heart Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-43757-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43757-6_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43755-2

  • Online ISBN: 978-3-319-43757-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation